Literature DB >> 16189271

Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.

Xin Huang1, Andrew C Wilber, Lei Bao, Dong Tuong, Jakub Tolar, Paul J Orchard, Bruce L Levine, Carl H June, R Scott McIvor, Bruce R Blazar, Xianzheng Zhou.   

Abstract

The Sleeping Beauty (SB) transposon system is a nonviral DNA delivery system in which a transposase directs integration of an SB transposon into TA-dinucleotide sites in the genome. To determine whether the SB transposon system can mediate stable gene expression in human T cells, primary peripheral blood lymphocytes (PBLs) were nucleofected with SB vectors carrying a DsRed reporter gene. Plasmids containing the SB transposase on the same molecule as (cis) or on a molecule separate from (trans) the SB transposon mediated long-term and stable reporter gene expression in human primary T cells. Sequencing of transposon:chromosome junctions confirmed that stable gene expression was due to SB-mediated transposition. In other studies, PBLs were successfully transfected using the SB transposon system and shown to stably express a fusion protein consisting of (1) a surface receptor useful for positive T-cell selection and (2) a "suicide" gene useful for elimination of transfected T cells after chemotherapy. This study is the first report demonstrating that the SB transposon system can mediate stable gene transfer in human primary PBLs, which may be advantageous for T-cell-based gene therapies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189271      PMCID: PMC1895607          DOI: 10.1182/blood-2005-05-2133

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  51 in total

1.  Gene therapy insertional mutagenesis insights.

Authors:  Utpal P Davé; Nancy A Jenkins; Neal G Copeland
Journal:  Science       Date:  2004-01-16       Impact factor: 47.728

2.  HIV-1 integration in the human genome favors active genes and local hotspots.

Authors:  Astrid R W Schröder; Paul Shinn; Huaming Chen; Charles Berry; Joseph R Ecker; Frederic Bushman
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

3.  Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system.

Authors:  Lalitha R Belur; Joel L Frandsen; Adam J Dupuy; David H Ingbar; David A Largaespada; Perry B Hackett; R Scott McIvor
Journal:  Mol Ther       Date:  2003-09       Impact factor: 11.454

4.  Human nerve growth factor receptor and cytosine deaminase fusion genes.

Authors:  Victor A Lewis; Lisa Basso; Noel Blake; Jill Salo; Troy C Lund; R Scott McIvor; Paul J Orchard
Journal:  Hum Gene Ther       Date:  2003-07-01       Impact factor: 5.695

5.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

6.  Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.

Authors:  Xianzheng Zhou; Yan Cui; Xin Huang; Zhiwei Yu; Amy M Thomas; Zhaohui Ye; Drew M Pardoll; Elizabeth M Jaffee; Linzhao Cheng
Journal:  Hum Gene Ther       Date:  2003-07-20       Impact factor: 5.695

Review 7.  Sleeping beauty transposition: biology and applications for molecular therapy.

Authors:  Zsuzsanna Izsvák; Zoltán Ivics
Journal:  Mol Ther       Date:  2004-02       Impact factor: 11.454

8.  Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene.

Authors:  Margaret Ramnaraine; Weihong Pan; Michael Goblirsch; Christine Lynch; Victor Lewis; Paul Orchard; Patrick Mantyh; Denis R Clohisy
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

9.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

10.  Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.

Authors:  Jacob Giehm Mikkelsen; Stephen R Yant; Leonard Meuse; Zan Huang; Hui Xu; Mark A Kay
Journal:  Mol Ther       Date:  2003-10       Impact factor: 11.454

View more
  40 in total

Review 1.  Designing T cells for cancer immunotherapy.

Authors:  Leslie E Huye; Gianpietro Dotti
Journal:  Discov Med       Date:  2010-04       Impact factor: 2.970

2.  Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells.

Authors:  Xin Huang; Kari Haley; Marianna Wong; Hongfeng Guo; Changming Lu; Andrew Wilber; Xianzheng Zhou
Journal:  Hum Gene Ther       Date:  2010-10-19       Impact factor: 5.695

3.  Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells.

Authors:  Xin Huang; Hongfeng Guo; Syam Tammana; Yong-Chul Jung; Emil Mellgren; Preetinder Bassi; Qing Cao; Zheng Jin Tu; Yeong C Kim; Stephen C Ekker; Xiaolin Wu; San Ming Wang; Xianzheng Zhou
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

Review 4.  Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials.

Authors:  D L DiGiusto; L J N Cooper
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

5.  Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.

Authors:  Teiko Sumiyoshi; Nathalia G Holt; Roger P Hollis; Shundi Ge; Paula M Cannon; Gay M Crooks; Donald B Kohn
Journal:  Hum Gene Ther       Date:  2009-12       Impact factor: 5.695

6.  Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes.

Authors:  Yozo Nakazawa; Leslie E Huye; Gianpietro Dotti; Aaron E Foster; Juan F Vera; Pallavi R Manuri; Carl H June; Cliona M Rooney; Matthew H Wilson
Journal:  J Immunother       Date:  2009-10       Impact factor: 4.456

7.  Genome-wide mapping of PiggyBac transposon integrations in primary human T cells.

Authors:  Daniel L Galvan; Yozo Nakazawa; Aparna Kaja; Claudia Kettlun; Laurence J N Cooper; Cliona M Rooney; Matthew H Wilson
Journal:  J Immunother       Date:  2009-10       Impact factor: 4.456

8.  Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase.

Authors:  Elmer B Santos; Raymond Yeh; James Lee; Yan Nikhamin; Blesida Punzalan; Blesserene Punzalan; Krista La Perle; Steven M Larson; Michel Sadelain; Renier J Brentjens
Journal:  Nat Med       Date:  2009-02-15       Impact factor: 53.440

9.  DNA transposons: nature and applications in genomics.

Authors:  Martín Muñoz-López; José L García-Pérez
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

10.  Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity.

Authors:  P D Peng; C J Cohen; S Yang; C Hsu; S Jones; Y Zhao; Z Zheng; S A Rosenberg; R A Morgan
Journal:  Gene Ther       Date:  2009-06-04       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.